Jeffrey N. Simmons net worth and biography

Jeffrey Simmons Biography and Net Worth

Jeff Simmons serves as president and chief executive officer of Elanco Animal Health. As a global leader with a 65-year track record of growth, Elanco provides comprehensive products and knowledge services to improve animal health, welfare and food animal production with 125 brands in 90 countries.

Jeff is a purpose-driven leader with nearly 30 years of experience delivering business results, engaging employees and developing the next generation of leaders. Jeff has directed the company’s transformation to a premier global player with a balanced and diversified business, having completed 12 acquisitions and built five new businesses, including a $1 billion companion animal business, and a leading aquaculture business. In 2018, Jeff navigated the company’s separation from Eli Lilly and Company, culminating with Elanco’s listing on the New York Stock Exchange as an independent public company solely dedicated to animal health. Most recently, he has orchestrated the company’s acquisition of companion animal start-up Aratana and the pending acquisition of Bayer Animal Health.

During his time with the company, Jeff has gained perspective on food and companionship that sparked a deep conviction for the power of healthy animals, and created a vision for Elanco centered on Food and Companionship Enriching Life

Healthier animals are the key to solving some of the world’s most pressing issues, such as food security and nutrition, human health and well-being, and environmental sustainability. Animals are the x-factor the world has been looking for – the game-changing variable that will unlock solutions to these seemingly disconnected issues of physical, mental and environmental health.

Jeff brings his passions for food security and enabling leaders to life daily through his pursuits with HATCH for Hunger™ and Edge Mentoring. As the co-founder of HATCH, Jeff and the team have created a unique model to sustainably deliver eggs to food banks across the country. Jeff also founded Edge Mentoring, one of the fastest-growing mentorship organizations in the country, designed to equip and accelerate whole-life excellence in leaders.

Simmons has also held a number of leadership positions, including serving as a former board member and chairman of the compensation committee for Chiquita Brands. He has completed terms as president of the Health for Animals, chairman of the FFA Foundation Board and as a board member of Gleaners Food Bank of Indiana.

What is Jeffrey N. Simmons' net worth?

The estimated net worth of Jeffrey N. Simmons is at least $396,900.00 as of March 10th, 2023. Mr. Simmons owns 45,000 shares of Elanco Animal Health stock worth more than $396,900 as of March 26th. This net worth evaluation does not reflect any other assets that Mr. Simmons may own. Learn More about Jeffrey N. Simmons' net worth.

What is Jeffrey N. Simmons' salary?

As the CEO of Elanco Animal Health Incorporated, Mr. Simmons earned a total compensation package of $12,060,015.00 in 2021. Mr. Simmons earned a salary of $1,046,000.00, stock awards of $9,261,019.00, non-equity compensation of $1,725,900.00, and other compensation of $27,096.00. Learn More on Jeffrey N. Simmons' salary.

How do I contact Jeffrey N. Simmons?

The corporate mailing address for Mr. Simmons and other Elanco Animal Health executives is 2500 INNOVATION WAY, GREENFIELD IN, 46140. Elanco Animal Health can also be reached via phone at (877) 352-6261 and via email at [email protected] Learn More on Jeffrey N. Simmons' contact information.

Has Jeffrey N. Simmons been buying or selling shares of Elanco Animal Health?

During the last ninety days, Jeffrey N. Simmons has bought $144,000.00 of Elanco Animal Health stock. Most recently, on Friday, March 10th, Jeffrey N. Simmons bought 15,000 shares of Elanco Animal Health stock. The stock was acquired at an average cost of $9.60 per share, with a total value of $144,000.00. Following the completion of the transaction, the chief executive officer now directly owns 45,000 shares of the company's stock, valued at $432,000. Learn More on Jeffrey N. Simmons' trading history.

Who are Elanco Animal Health's active insiders?

Elanco Animal Health's insider roster includes John Bilbrey (Director), Art Garcia (Director), Michael Harrington (Director), R. Hoover (Director), Jeffrey Simmons (CEO), and Todd Young (Insider). Learn More on Elanco Animal Health's active insiders.

Are insiders buying or selling shares of Elanco Animal Health?

During the last year, Elanco Animal Health insiders bought shares 8 times. They purchased a total of 109,200 shares worth more than $1,647,830.00. The most recent insider tranaction occured on March, 10th when CEO Jeffrey N Simmons bought 15,000 shares worth more than $144,000.00. Insiders at Elanco Animal Health own 6.4% of the company. Learn More about insider trades at Elanco Animal Health.

Information on this page was last updated on 3/10/2023.

Jeffrey N. Simmons Insider Trading History at Elanco Animal Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/10/2023Buy15,000$9.60$144,000.0045,000View SEC Filing Icon  
9/9/2022Buy30,000$14.54$436,200.0030,000View SEC Filing Icon  
8/11/2021Buy16,850$29.70$500,445.00568,577View SEC Filing Icon  
9/4/2019Buy75,750$26.55$2,011,162.50470,006View SEC Filing Icon  
9/24/2018Buy22,000$24.00$528,000.00View SEC Filing Icon  
See Full Table

Jeffrey N. Simmons Buying and Selling Activity at Elanco Animal Health

This chart shows Jeffrey N Simmons's buying and selling at Elanco Animal Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Elanco Animal Health Company Overview

Elanco Animal Health logo
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants &
Read More

Today's Range

Now: $8.82
Low: $8.68
High: $8.97

50 Day Range

MA: $11.93
Low: $8.79
High: $14.58

2 Week Range

Now: $8.82
Low: $8.68
High: $27.68


12,751,731 shs

Average Volume

9,066,743 shs

Market Capitalization

$4.34 billion

P/E Ratio


Dividend Yield